Patents by Inventor Kevin Otipoby

Kevin Otipoby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240132591
    Abstract: The disclosure relates to methods and compositions for treating Type 1 diabetes, such as compositions comprising an effector domain linked to a protein that binds to MAdCAM.
    Type: Application
    Filed: February 22, 2022
    Publication date: April 25, 2024
    Applicant: PANDION OPERATIONS, INC.
    Inventors: Daniel RIOS, Kevin OTIPOBY, Joanne L. VINEY, Nathan HIGGINSON-SCOTT
  • Publication number: 20230235004
    Abstract: Methods and compounds for conferring site-specific or local immune privilege.
    Type: Application
    Filed: February 19, 2021
    Publication date: July 27, 2023
    Applicant: PANDION OPERATIONS, INC.
    Inventors: Joanne L. VINEY, Nathan HIGGINSON-SCOTT, Kevin OTIPOBY, Daniel RIOS, Susmita BORTHAKUR, Salvatore ALIOTO, Lindsay EDWARDS
  • Patent number: 10280169
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: December 11, 2014
    Date of Patent: May 7, 2019
    Assignee: BIOGEN MA INC.
    Inventors: Brian T. Hopkins, Bin Ma, Timothy Raymond Chan, Gnanasambandam Kumaravel, Hua Miao, Andrea Bertolotti-Ciarlet, Kevin Otipoby
  • Publication number: 20160318935
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: December 11, 2014
    Publication date: November 3, 2016
    Inventors: Brian T. Hopkins, Bin Ma, Timothy Raymond Chan, Gnanasambandam Kumaravel, Hua Miao, Andrea Bertolotti-Ciarlet, Kevin Otipoby